# FR901228 in Treating Patients With Hematologic Cancer

> **NCT00024180** · PHASE1 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** romidepsin

## Key facts

- **NCT ID:** NCT00024180
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024180, "FR901228 in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00024180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*